In vivo CAR T-cell generation is emerging as a transformative strategy—streamlining production, reducing costs, and reshaping immune-based treatment, with inflammatory pathways central to efficacy.
#CART #Immunotherapy #CellTherapy #InflammationScience
doi.org/10.1016/j.ge...
0
0
0
0